• Explore /
  • Poster
  • / Role of anthracyclines in neoadjuvant anti-HER2 regimens for HER2+ breast cancer (BC): A network meta-analysis (NMA).

Role of anthracyclines in neoadjuvant anti-HER2 regimens for HER2+ breast cancer (BC): A network meta-analysis (NMA).

Abstract Poster

Authors

null

Giacomo Pelizzari

Department of Medicine (DAME), University of Udine; Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Udine, Italy

Giacomo Pelizzari , Lorenzo Gerratana , Debora Basile , Michele Bartoletti , Camilla Lisanti , Silvio Ken Garattini , Lucia Bortot , Carla Corvaja , Silvia Buriolla , Gianluca Curtolo , Mattia Garutti , Paola Di Nardo , Elena Torrisi , Lucia Da Ros , Andrea Freschi , Silvana Saracchini , Silvia Bolzonello , Gianmaria Miolo , Simon Spazzapan , Fabio Puglisi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 37, 2019 (suppl; abstr 577)

DOI

10.1200/JCO.2019.37.15_suppl.577

Abstract #

577

Poster Bd #

69

Abstract Disclosures

Similar Posters

First Author: Rashmi Krishna Murthy

First Author: M. Luque

First Author: Christian F. Singer

First Author: Hong-Fei Gao